• Definition: benign capillary vascular tumor of infancy
  • Epidemiology
    • Occurs in 3–10% of infants
    • More commonly affects girls
  • Pathophysiology
    • Abnormal development of vascular endothelial cells
    • Rapid proliferation followed by subsequent spontaneous slow involution (occurring at the age of 5–8 years)
    • Spontaneous resolution is common
  • Clinical course:
    • Absent/faint at birth → rapid proliferation 3–9 mo → spontaneous involution (50% by age 5, 90% by age 9).
    • Superficial = bright red “strawberry” plaque; deep = bluish, doughy subcutaneous mass.
    • High-risk locations:
      • Periocular → visual axis obstruction, amblyopia, astigmatism.
      • “Beard” area → subglottic/airway hemangioma (biphasic stridor).
      • Lumbosacral → spinal dysraphism/tethered cord.
      • ≥5 cutaneous lesions → hepatic hemangiomas (high-output HF).
      • Segmental facial >5 cm → PHACE syndrome.
  • DDx:
    • Port-wine stain: present at birth, grows proportionally, never involutes, GLUT-1 (−).
    • Congenital hemangioma (RICH/NICH): fully formed at birth, GLUT-1 (−).
    • Pyogenic granuloma: older child, friable, bleeds with trauma.
    • Kaposiform hemangioendothelioma: purpuric plaque + Kasabach-Merritt (consumptive thrombocytopenia).
    • Nevus simplex: flat, midline, fades spontaneously.
  • Management:
    • Uncomplicated → observation + reassurance (most involute).
    • High-risk (vision/airway compromise, ulceration, disfigurement, HF) → oral propranolol (1st line; monitor hypoglycemia, bradycardia, hypotension). c
    • Small superficial lesion → topical timolol.
    • Propranolol CI/failure → systemic corticosteroids.
    • Refractory → pulsed-dye laser (ulceration/telangiectasias), surgical excision.